Medidata Solutions Honored by Frost & Sullivan as 2006 Healthcare IT Entrepreneurial Company of the Year
FOR IMMEDIATE RELEASE
Medidata Solutions Honored by Frost & Sullivan as
2006 Healthcare IT Entrepreneurial Company of the Year
Record Growth and Success in Global Healthcare Markets
Positions Company as Leader in E-Clinical Technology and Services
NEW YORK, NY – October 11, 2006 – Medidata Solutions, a global provider of electronic clinical data capture (EDC), management and reporting solutions, today announced their selection as recipient of Frost & Sullivan’s 2006 North American Healthcare Information Technologies Entrepreneurial Company of the Year. Frost and Sullivan evaluated the company’s success within the 2000 to 2004 time period, and with an impressive growth rate of 9,216 percent, Medidata was recognized for its strategic evolution into a market-leading provider of clinical trial technology and services.
Medidata’s strong global presence, flexible technology platform, robust services, strategic partnerships, successful marketing strategies and sound financial management drove Frost & Sullivan analysts to choose the company as a leader in the space. In a competitive market, Medidata Solutions has successfully built a diverse customer base which includes the world’s leading pharmaceutical, biotech and medical device companies and research organizations.
“By continually enhancing our Medidata Rave® EDC solution and product support services, we have been able to meet the changing needs in the market, win the confidence of the end user and build an extremely loyal customer base,” said Tarek Sherif, CEO of Medidata Solutions. “We are honored to be recognized by Frost & Sullivan for our ability to execute our global growth strategy for providing the pharmaceutical industry with a technology platform that drives clinical trials efficiencies and streamlines business processes.”
The Frost & Sullivan Healthcare Information Technologies Entrepreneurial Company of the Year Award is bestowed each year upon the company that has demonstrated entrepreneurial ability in the industry. Through extensive interviews with Frost & Sullivan analyst teams, participants are compared based on their strategy for growth, strategic alliances, expected time to market and senior management team.
“With a highly flexible and extensible solution, solid management team and critical industry partnerships, Medidata Solutions has achieved rapid growth and secured a leading position in an emerging market,” said Frost & Sullivan research analyst Nilakantan Rajaraman. “Our recognition of Medidata Solutions speaks to the company’s sound business strategy, established presence in the EDC space and emergence as a pioneer in leading-edge solutions for the next generation of clinical trial methodologies.”
About Frost & Sullivan Best Practices
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.awards.frost.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing lifeenhancing treatments to market—on five continents and in more than 70 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com